Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in Qatar
Authors:
- Layan SukikLSLayan Sukik
- Hiam ChemaitellyHCHiam Chemaitelly
- Houssein H AyoubHAHoussein H Ayoub
- Patrick TangPTPatrick Tang
- Mohammad R HasanMHMohammad R Hasan
- Asmaa A Al ThaniATAsmaa A Al Thani
- Einas Al-KuwariEAEinas Al-Kuwari
- Andrew JeremijenkoAJAndrew Jeremijenko
- Anvar Hassan KaleeckalAKAnvar Hassan Kaleeckal
Open Access
- 17 February 2025
- journal article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (3) , ofaf098
Abstract
Background: Accurately assessing SARS-CoV-2 infection severity is essential for understanding the health impact of the infection and evaluating the effectiveness of interventions. This study investigated whether SARS-CoV-2–associated hospitalizations can reliably measure true COVID-19 severity. Methods: The diagnostic accuracy of SARS-CoV-2–associated acute care and ICU hospitalizations as indicators of infection severity was assessed in Qatar from 6 September 2021 to 13 May 2024. WHO criteria for severe, critical, and fatal COVID-19 served as the reference standard. Two indicators were assessed: (1) any SARS-CoV-2–associated hospitalization in acute care or ICU beds and (2) ICU-only hospitalizations. Results: A total of 644 176 SARS-CoV-2 infections were analyzed. The percent agreement between any SARS-CoV-2–associated hospitalization (acute care or ICU) and WHO criteria was 98.7% (95% confidence interval (CI), 98.6–98.7); however, Cohen's kappa was only 0.17 (95% CI, 0.16–0.18), indicating poor agreement. Sensitivity, specificity, PPV, and negative predictive value were 100% (95% CI, 99.6–100), 98.7% (95% CI, 98.6–98.7), 9.7% (95% CI, 9.1–10.3), and 100% (95% CI, 100–100), respectively. For SARS-CoV-2–associated ICU-only hospitalizations, the percent agreement was 99.8% (95% CI, 99.8–99.9), with a kappa of 0.47 (95% CI, 0.44–0.50), indicating fair-to-good agreement. Sensitivity, specificity, PPV, and negative predictive value were 46.6% (95% CI, 43.4–49.9), 99.9% (95% CI, 99.9–99.9), 47.9% (95% CI, 44.6–51.2), and 99.9% (95% CI, 99.9–99.9), respectively. Conclusions: Generic hospital admissions are unreliable indicators of COVID-19 severity, whereas ICU admissions are somewhat more accurate. The findings demonstrate the importance of applying specific, robust criteria—such as WHO criteria—to reduce bias in epidemiological and vaccine effectiveness studies.Keywords
This publication has 40 references indexed in Scilit:
- Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in QatarNew England Journal of Medicine, 2022
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in QatarNew England Journal of Medicine, 2021
- Severity of SARS-CoV-2 Reinfections as Compared with Primary InfectionsNew England Journal of Medicine, 2021
- Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020Global Epidemiology, 2021
- Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta VariantClinical Infectious Diseases, 2021
- SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in QatarScientific Reports, 2021
- Characterizing the Qatar advanced-phase SARS-CoV-2 epidemicScientific Reports, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling AnalysesVaccines, 2020
- Estimating the effects of non-pharmaceutical interventions on COVID-19 in EuropeNature, 2020